Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice.
Alcoholism
/ blood
Animals
Anxiety
/ drug therapy
Brain
/ metabolism
Clinical Trials as Topic
Diet, Ketogenic
Dietary Supplements
Ethanol
/ administration & dosage
Glucose
Humans
Ketone Bodies
/ metabolism
Ketones
/ therapeutic use
Male
Mice
Mice, Inbred C57BL
Rats
Substance Withdrawal Syndrome
/ metabolism
Alcohol dependence
Alcohol withdrawal
Alcoholism
Anxiety-like behavior
Detoxification
Ethanol
Ketone bodies
Ketone monoester
Mice
Journal
Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
24
06
2020
accepted:
24
11
2020
pubmed:
8
1
2021
medline:
16
3
2021
entrez:
7
1
2021
Statut:
ppublish
Résumé
After alcohol ingestion, the brain partly switches from consumption of glucose to consumption of the alcohol metabolite acetate. In heavy drinkers, the switch persists after abrupt abstinence, leading to the hypothesis that the resting brain may be "starved" when acetate levels suddenly drop during abstinence, despite normal blood glucose, contributing to withdrawal symptoms. We hypothesized that ketone bodies, like acetate, could act as alternative fuels in the brain and alleviate withdrawal symptoms. We previously reported that a ketogenic diet during alcohol exposure reduced acute withdrawal symptoms in rats. Here, our goals were to test whether (1) we could reproduce our findings, in mice and with longer alcohol exposure; (2) ketone bodies alone are sufficient to reduce withdrawal symptoms (clarifying mechanism); (3) introduction of ketogenic diets at abstinence (a clinically more practical implementation) would also be effective. Male C57BL/6NTac mice had intermittent alcohol exposure for 3 weeks using liquid diet. Somatic alcohol withdrawal symptoms were measured as handling-induced convulsions; anxiety-like behavior was measured using the light-dark transition test. We tested a ketogenic diet, and a ketone monoester supplement with a regular carbohydrate-containing diet. The regular diet with ketone monoester was sufficient to reduce handling-induced convulsions and anxiety-like behaviors in early withdrawal. Only the ketone monoester reduced handling-induced convulsions when given during abstinence, consistent with faster elevation of blood ketones, relative to ketogenic diet. These findings support the potential utility of therapeutic ketosis as an adjunctive treatment in early detoxification in alcohol-dependent patients seeking to become abstinent. clinicaltrials.gov NCT03878225, NCT03255031.
Identifiants
pubmed: 33410985
doi: 10.1007/s00213-020-05735-1
pii: 10.1007/s00213-020-05735-1
pmc: PMC7914216
mid: NIHMS1661196
doi:
Substances chimiques
Ketone Bodies
0
Ketones
0
Ethanol
3K9958V90M
Glucose
IY9XDZ35W2
Banques de données
ClinicalTrials.gov
['NCT03255031', 'NCT03878225']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
833-844Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA021984
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01DK108283
Pays : United States
Organisme : Ivan Nielsen Foundation (DK)
ID : n/a
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01AA025071
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01AA021984
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA025071
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK108283
Pays : United States
Organisme : Region Hovedstaden
ID : n/a
Organisme : Sundhed og Sygdom, Det Frie Forskningsråd
ID : 0134-00044B
Références
FASEB J. 2012 Jun;26(6):2351-62
pubmed: 22362892
In Silico Pharmacol. 2013 May 17;1:7
pubmed: 25505652
Behav Neural Biol. 1979 Dec;27(4):466-86
pubmed: 575037
J Intern Med. 1998 Nov;244(5):387-95
pubmed: 9845854
Neuropharmacology. 2017 Aug 1;122:85-99
pubmed: 28108359
Am J Physiol. 1995 Jun;268(6 Pt 1):E1161-6
pubmed: 7611392
J Biol Chem. 2010 Aug 20;285(34):25950-6
pubmed: 20529850
Neurosci Biobehav Rev. 2005 Jan;28(8):837-50
pubmed: 15642625
Neuropharmacology. 2020 Aug 1;172:108129
pubmed: 32418906
Microbiome. 2017 Oct 17;5(1):141
pubmed: 29041989
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Jan;25(1):141-66
pubmed: 11263750
Brain Res. 1975 Jan 17;83(3):437-49
pubmed: 234271
Toxicol Lett. 2018 May 1;287:23-30
pubmed: 29391279
Regul Toxicol Pharmacol. 2012 Aug;63(3):401-8
pubmed: 22561291
Am J Physiol. 1995 Apr;268(4 Pt 1):E660-7
pubmed: 7733265
eNeuro. 2019 Apr 24;6(2):
pubmed: 31058214
J Neurosci. 1998 Jul 15;18(14):5225-33
pubmed: 9651205
Sleep Med Rev. 2003 Dec;7(6):523-39
pubmed: 15018094
Alcohol Clin Exp Res. 2014 Oct;38(10):2664-77
pubmed: 25346507
Alcohol Clin Exp Res. 2019 Sep;43(9):1838-1847
pubmed: 31237693
Nutr Neurosci. 2011 Mar;14(2):51-8
pubmed: 21605500
Alcohol Alcohol. 1993 Jul;28(4):431-6
pubmed: 8104400
Expert Opin Drug Saf. 2016 Oct;15(10):1313-9
pubmed: 27501204
Subst Use Misuse. 2001 Jun;36(8):1085-109
pubmed: 11504154
J Cereb Blood Flow Metab. 2017 Jul;37(7):2485-2493
pubmed: 27629100
Addict Behav. 2019 Jan;88:48-55
pubmed: 30142484
Alcohol Clin Exp Res. 1990 Jun;14(3):482-9
pubmed: 2198826
Alcohol Health Res World. 1997;21(2):149-56
pubmed: 15704352
Front Mol Neurosci. 2017 Jul 25;10:235
pubmed: 28790891
J Cereb Blood Flow Metab. 2011 Dec;31(12):2313-23
pubmed: 21731032
Regul Toxicol Pharmacol. 2012 Jul;63(2):196-208
pubmed: 22504461
J Neurosci. 2002 Mar 1;22(5):1523-31
pubmed: 11880482
Neuropharmacology. 2018 May 1;133:233-241
pubmed: 29325899
Alcohol Clin Exp Res. 2004 Oct;28(10):1459-68
pubmed: 15597077
Pharmacol Biochem Behav. 2017 Sep;160:14-20
pubmed: 28778739
Neurochem Int. 2001 May;38(6):519-27
pubmed: 11248400
Stress. 2004 Jun;7(2):97-107
pubmed: 15512853
Am J Physiol. 1975 Nov;229(5):1165-9
pubmed: 1200135
Psychiatry Res. 1990 Apr;35(1):39-48
pubmed: 2164230
Mol Autism. 2016 Sep 01;7(1):37
pubmed: 27594980
Alcohol Alcohol. 2016 Jan;51(1):27-31
pubmed: 26071564
Am J Physiol Regul Integr Comp Physiol. 2013 May 15;304(10):R829-36
pubmed: 23552496
Handb Clin Neurol. 2014;125:133-56
pubmed: 25307573
Behav Neurosci. 2005 Aug;119(4):911-25
pubmed: 16187819
Am J Physiol. 1986 Feb;250(2 Pt 1):E169-78
pubmed: 2937307
Dev Neurosci. 2018;40(5-6):451-462
pubmed: 31085911
Drugs Aging. 2002;19(8):583-94
pubmed: 12207552
Neurosci Lett. 2017 Mar 6;642:158-162
pubmed: 28189745
Alcohol Clin Exp Res. 2002 Aug;26(8):1259-68
pubmed: 12198403
Neuroimage. 2006 Jan 1;29(1):295-301
pubmed: 16085426
Alcohol Clin Exp Res. 2010 Feb;34(2):375-81
pubmed: 19951290
J Pharmacol Exp Ther. 1996 Oct;279(1):128-36
pubmed: 8858985
Emerg Med J. 2006 Jun;23(6):417-20
pubmed: 16714496
Alcohol Clin Exp Res. 2004 Jul;28(7):1012-9
pubmed: 15252287
Curr Opin Neurol. 2017 Apr;30(2):187-192
pubmed: 28141738
J Neurosci. 2009 Jan 28;29(4):1087-92
pubmed: 19176817
Alcohol Clin Exp Res. 2018 Feb;42(2):270-277
pubmed: 29160944
FASEB J. 2016 Dec;30(12):4021-4032
pubmed: 27528626
J Clin Invest. 2013 Apr;123(4):1605-14
pubmed: 23478412
Behav Brain Res. 2017 Apr 14;323:172-176
pubmed: 28161446
Am J Psychiatry. 1993 Mar;150(3):417-22
pubmed: 8382010
Biol Psychiatry. 2012 Jun 1;71(11):1015-21
pubmed: 21907974
Neuroimage. 2013 Jan 1;64:277-83
pubmed: 22947541
Sci Rep. 2018 Apr 27;8(1):6670
pubmed: 29703936
Drug Alcohol Depend. 2017 Oct 1;179:229-239
pubmed: 28806640
Alcohol Alcohol. 2017 Jul 1;52(4):403-413
pubmed: 28482009
Subst Abuse. 2013 Jun 04;7:117-26
pubmed: 23861588
Cell. 2018 Jul 12;174(2):497
pubmed: 30007420
J Clin Invest. 1970 Oct;49(10):1775-82
pubmed: 5456793
Alcohol Alcohol. 2003 Nov-Dec;38(6):613-8
pubmed: 14633651
Drug Alcohol Depend. 2008 Sep 1;97(1-2):86-93
pubmed: 18479843
Brain Res. 1991 May 31;550(1):1-6
pubmed: 1888987
J Nutr. 1971 Dec;101(12):1719-26
pubmed: 4399481
Lancet. 2016 Mar 5;387(10022):988-998
pubmed: 26343838
Am J Physiol. 1996 May;270(5 Pt 1):E746-51
pubmed: 8967461
J Inherit Metab Dis. 2005;28(2):109-21
pubmed: 15877199
J Cereb Blood Flow Metab. 2002 Jul;22(7):890-8
pubmed: 12142574
Acta Neurol Scand. 1983 Jan;67(1):3-25
pubmed: 6301198
J Lipid Res. 1979 Mar;20(3):289-315
pubmed: 87483
Regul Toxicol Pharmacol. 2019 Dec;109:104506
pubmed: 31655093
J Neurosci. 2015 Feb 18;35(7):3248-55
pubmed: 25698759
Alcohol Clin Exp Res. 2017 Feb;41(2):421-431
pubmed: 28060415
Front Mol Neurosci. 2016 Dec 06;9:137
pubmed: 27999529
Addict Biol. 2010 Apr;15(2):169-84
pubmed: 20148778
J Appl Physiol. 1972 May;32(5):664-8
pubmed: 5038855
Neuropharmacology. 2019 Apr;148:21-30
pubmed: 30562540
Curr Protoc Neurosci. 2005 Aug;Chapter 9:Unit 9.20
pubmed: 18428629
J Neurochem. 2005 Feb;92(4):934-47
pubmed: 15686496
J Stud Alcohol. 1998 Nov;59(6):640-6
pubmed: 9811085
Neurochem Res. 2017 Jan;42(1):35-49
pubmed: 27826689
Neurobiol Aging. 2013 Jun;34(6):1530-9
pubmed: 23276384
Neuropsychopharmacology. 2018 Aug;43(9):1915-1923
pubmed: 29907878